Tuesday was a nice day for some big biotech namesBiogen Inc(BIIB) soared more than 25% on improving prospects for a New Drug Application (NDA) submission with the Food and Drug Administration (FDA) for its Alzheimer's drug, which had been given up for dead earlier this yearI posted a quick take on that new study data Tuesday morning right after th...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.